Cell Growth & Differentiation, Vol 7, Issue 6 689-697, Copyright © 1996 by American Association of Cancer Research

ARTICLES

The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis

B Shan, AA Farmer and WH Lee
Center for Molecular Medicine/Institute of Biotechnology, University of Texas Health Science Center at San Antonio 78245, USA.

The transcription factor E2F plays a critical role in the G1 to S transition. E2F is a heterodimer formed by members of the E2F and DP families of DNA-binding proteins. Ectopic expression of E2F-1, the first member of the E2F family identified, is sufficient to cause quiescent cells to enter S phase. Thus, the biological significance of the interaction of E2F-1 with its DP protein partner, DP-1, was unclear. Here, we report on the role of DP-1 in the mediation of E2F-induced S-phase entry and apoptosis. Cells inducible for DP-1, E2F-1, or both were established and characterized. Ectopic expression of DP-1 alone fails to promote cell cycle entry, even when the potent transactivation domain of human papillomavirus-VP16 is fused to the DNA-binding domain of DP-1. In contrast, coexpression of DP-1 and E2F-1 results in greater loss of G1 regulation and significantly more apoptosis than does E2F-1 alone. Using clones co-inducible for DP-1 and E2F-1, expression of potential target genes of E2F activity that may account for its ability to induce S-phase entry was also examined. Induction of E2F-1/DP-1 resulted in increased expression and activity of cyclins A and E, as well as CDK2, prior to S-phase entry. Cyclin D and CDK4, however, were not induced. Phosphorylation of the retinoblastoma protein is also increased following induction of E2F-1/DP-1, suggesting that E2F can feed-back on the retinoblastoma protein, presumably through activation of cyclin A- and/or E-associated kinase activity.

This article has been cited by other articles:

				C. Zhang, K. Lundgren, Z. Yan, M. E. Arango, S. Price, A. Huber, J. Higgins, G. Troche, J. Skaptason, T. Koudriakova, et al. Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy Mol. Cancer Ther., April 1, 2008; 7(4): 818 - 828. [Abstract] [Full Text] [PDF]

				S. V. Sharma and J. Settleman Oncogene addiction: setting the stage for molecularly targeted cancer therapy Genes & Dev., December 15, 2007; 21(24): 3214 - 3231. [Abstract] [Full Text] [PDF]

				S. A. Vorburger, N. Hetrakul, W. Xia, M. Wilson-Heiner, N. Mirza, R. E. Pollock, B. Feig, S. G. Swisher, and K. K. Hunt Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo Mol. Cancer Ther., November 1, 2005; 4(11): 1710 - 1716. [Abstract] [Full Text] [PDF]

				F. I. Raynaud, S. R. Whittaker, P. M. Fischer, S. McClue, M. I. Walton, S. E. Barrie, M. D. Garrett, P. Rogers, S. J. Clarke, L. R. Kelland, et al. In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202 Clin. Cancer Res., July 1, 2005; 11(13): 4875 - 4887. [Abstract] [Full Text] [PDF]

				J. H. Lieman, L. A. Worley, and J. W. Harbour Loss of Rb-E2F Repression Results in Caspase-8-mediated Apoptosis through Inactivation of Focal Adhesion Kinase J. Biol. Chem., March 18, 2005; 280(11): 10484 - 10490. [Abstract] [Full Text] [PDF]

				M. L. Spencer, M. Theodosiou, and D. J. Noonan NPDC-1, a Novel Regulator of Neuronal Proliferation, Is Degraded by the Ubiquitin/Proteasome System through a PEST Degradation Motif J. Biol. Chem., August 27, 2004; 279(35): 37069 - 37078. [Abstract] [Full Text] [PDF]

				S. R. Whittaker, M. I. Walton, M. D. Garrett, and P. Workman The Cyclin-dependent Kinase Inhibitor CYC202 (R-Roscovitine) Inhibits Retinoblastoma Protein Phosphorylation, Causes Loss of Cyclin D1, and Activates the Mitogen-activated Protein Kinase Pathway Cancer Res., January 1, 2004; 64(1): 262 - 272. [Abstract] [Full Text] [PDF]

				D. Ma, P. Zhou, and J. W. Harbour Distinct Mechanisms for Regulating the Tumor Suppressor and Antiapoptotic Functions of Rb J. Biol. Chem., May 23, 2003; 278(21): 19358 - 19366. [Abstract] [Full Text] [PDF]

				S. A. Vorburger, A. Pataer, K. Yoshida, Y. Liu, X. Lu, S. G. Swisher, and K. K. Hunt The Mitochondrial Apoptosis-Inducing Factor Plays a Role in E2F-1-Induced Apoptosis in Human Colon Cancer Cells Ann. Surg. Oncol., April 1, 2003; 10(3): 314 - 322. [Abstract] [Full Text] [PDF]

				L. Farhana, M. Dawson, A. K. Rishi, Y. Zhang, E. Van Buren, C. Trivedi, U. Reichert, G. Fang, M. W. Kirschner, and J. A. Fontana Cyclin B and E2F-1 Expression in Prostate Carcinoma Cells Treated with the Novel Retinoid CD437 Are Regulated by the Ubiquitin-mediated Pathway Cancer Res., July 1, 2002; 62(13): 3842 - 3849. [Abstract] [Full Text] [PDF]

				C. Park, I. Lee, and W. K. Kang Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death Carcinogenesis, October 1, 2001; 22(10): 1727 - 1731. [Abstract] [Full Text] [PDF]

				R. Halaban, E. Cheng, Y. Smicun, and J. Germino Deregulated E2F Transcriptional Activity in Autonomously Growing Melanoma Cells J. Exp. Med., March 20, 2000; 191(6): 1005 - 1016. [Abstract] [Full Text] [PDF]

				O. Loughran and N. B. La Thangue Apoptotic and Growth-Promoting Activity of E2F Modulated by MDM2 Mol. Cell. Biol., March 15, 2000; 20(6): 2186 - 2197. [Abstract] [Full Text]

				S. Yamano, T. Tokino, M. Yasuda, M. Kaneuchi, M. Takahashi, Y. Niitsu, K. Fujinaga, and T. Yamashita Induction of Transformation and p53-Dependent Apoptosis by Adenovirus Type 5 E4orf6/7 cDNA J. Virol., December 1, 1999; 73(12): 10095 - 10103. [Abstract] [Full Text]

				J. Padmanabhan, D. S. Park, L. A. Greene, and M. L. Shelanski Role of Cell Cycle Regulatory Proteins in Cerebellar Granule Neuron Apoptosis J. Neurosci., October 15, 1999; 19(20): 8747 - 8756. [Abstract] [Full Text] [PDF]

				P. M. Ojala, M. Tiainen, P. Salven, T. Veikkola, E. Castanos-Velez, R. Sarid, P. Biberfeld, and T. P. Makela Kaposi's Sarcoma-associated Herpesvirus-encoded v-Cyclin Triggers Apoptosis in Cells with High Levels of Cyclin-dependent Kinase 6 Cancer Res., October 1, 1999; 59(19): 4984 - 4989. [Abstract] [Full Text] [PDF]

				K. W. Kohn Molecular Interaction Map of the Mammalian Cell Cycle Control and DNA Repair Systems Mol. Biol. Cell, August 1, 1999; 10(8): 2703 - 2734. [Abstract] [Full Text]

				P. A. Kirkham, E. W.-F. Lam, H.-H. Takamatsu, R. Michael, and E. Parkhouse Transcription Factor E2F Controls the Reversible {gamma}{delta} T Cell Growth Arrest Mediated Through WC1 J. Immunol., August 15, 1998; 161(4): 1630 - 1636. [Abstract] [Full Text] [PDF]

				E. W.-F. Lam, M. S. K. Choi, J. van der Sman, S. A. Burbidge, and G. G. B. Klaus Modulation of E2F Activity via Signaling through Surface IgM and CD40 Receptors in WEHI-231 B Lymphoma Cells J. Biol. Chem., April 17, 1998; 273(16): 10051 - 10057. [Abstract] [Full Text] [PDF]

				J K Hsieh, S Fredersdorf, T Kouzarides, K Martin, and X Lu E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes & Dev., July 15, 1997; 11(14): 1840 - 1852. [Abstract] [PDF]